The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2009

Filed:

May. 07, 1999
Applicants:

Kathryn Lesley Armour, Cambridge, GB;

Michael Ronald Clark, Cambridge, GB;

Lorna Mcleod Williamson, Cambridge, GB;

Inventors:

Kathryn Lesley Armour, Cambridge, GB;

Michael Ronald Clark, Cambridge, GB;

Lorna McLeod Williamson, Cambridge, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C12P 21/08 (2006.01); C12N 15/11 (2006.01); C12N 15/13 (2006.01); C07K 16/28 (2006.01); C07K 16/34 (2006.01); C07H 15/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are binding molecules which are recombinant polypeptides containing: (i) a binding domain capable of binding a target molecule, and (ii) an effector domain having an amino acid sequence substantially homologous to all or part of a constant domain of a human immunoglobulin heavy chain; characterized in that the binding molecule is capable of binding the target molecule without triggering significant complement dependent lysis, or cell mediated destruction of the target, and more preferably wherein the effector domain is capable of specifically binding FcRn and/or FcγRIIb. These are generally based on chimeric domains which are derived from two or more human immunoglobulin heavy chain CH2 domains domains. In preferred embodiments the regions 233-236, and 327-331, are modified, as are further residues to render the molecule null allotypic. Also disclosed are nucleic acids, host cells, production processes and materials, and uses. Pharmaceutical preparations are also disclosed.


Find Patent Forward Citations

Loading…